CAS 131926-99-3: LANSOPRAZOLE SULFONE

Lansoprazole sulfone

Lansoprazole impurity standard

Compounds containing an unfused pyridine ring in the structure, nesoi

Lansoprazole is a proton pump inhibitor that is used in the treatment of gastrointestinal ulcers, symptoms of GERD and to eradicate Helicobacter pylori. This drug works by decreasing gastric acid secretion by targeting H+ and K+ ATPase. It offers pain relief from heartburn and reduces ulcer related pain. Lansoprazole sulfone is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Lansoprazole sulfone is a prodrug of lansoprazole that is metabolized by cytochrome P450 enzymes. Lansoprazole sulfone has a pharmacokinetic profile similar to the parent drug and is used to treat gastroesophageal reflux disease in adults. The human pharmacokinetics of lansoprazole sulfone have been determined using recombinant cytochrome P450 enzymes and analytical methods. Lansoprazole sulfone has been shown to be effective against gastric acid secretion, with an activity index of 0.15-0.3 for inhibiting gastric acid secretion. It also has low protein binding properties, which may result in drug interactions with other drugs or foods that have high protein binding properties.

Lansoprazole sulfone is a metabolite of the gastric pump inhibitor Lansoprazole.

Impurity Lansoprazole USP Related Compound A Applications A metabolite of Lansoprazole, as gastric pump inhibitor. Lansoprazole USP Related Compound A. References De Morais, S., et al.: Mol. Pharmacol., 46, 594 (1994), Spencer, C., et al.: Drugs, 48, 404 (1994), Pearce, R., et al.: J. Pharmacol. Exp. Ther., 277, 805 (1996), Tassaneeyakul, W., et al.: Br. J. Clin. Pharmacol., 49, 139 (2000),